Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 10,000 shares at $34.10 ($341K) on 2014-07-01, disclosed to the SEC on 2014-07-02.
Scheduled sale ($341k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.09 | 7,500 | $256K | 75.0% |
| 2 | $34.10 | 2,500 | $85K | 25.0% |
| Total | $34.09 avg | 10,000 | $341K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |